Walker on Progress

FTI Consulting's new CHRO isn't just a leadership change. It's a strategic move to double down on the one asset that fuels its growth: its people.

Target RWE's strategic hire of NoviSci co-founder Alan Brookhart signals a major push to master regulatory-grade real-world evidence. What does this mean?

As consumer debt soars, a key advocacy group's new data-focused leadership could turn a powerful analytical lens on the role of healthcare and drug prices.

With a new SVP of Growth, John Henry, RestorixHealth signals an aggressive push in the booming wound care market, navigating tech shifts and regulatory hurdles.

ATI Inc. names operational veteran Rob Foster as its new CFO, signaling a strategic bet that manufacturing prowess is the key to financial success.

A leadership shift at a regional financial powerhouse offers a compelling case study on strategy, innovation, and stakeholder management for biopharma leaders.

A strategic partnership integrates cutting-edge AI into drug development, promising to slash timelines and costs. Is this the new blueprint for pharma R&D?

Cambridge biotech Atavistik Bio reveals a novel allosteric inhibitor targeting a key MPN mutation, promising disease modification without current side effects.

A new partnership aims to merge AI credit scoring with blockchain to tokenize auto loans, targeting a massive traditional finance market for disruption.

With co-founder Kathy Gersch as CEO, Kotter is poised to guide pharma through its next wave of disruption. What does this mean for industry leaders?

With animal trials failing 90% of the time, a new consortium aims to standardize organoid models, promising faster, cheaper, and more human-relevant drug discovery.

Sutton Group appoints a RE/MAX veteran to lead its Eastern expansion, signaling a major push into tech-driven real estate and wealth management.

A barbecue brand's grant to a fire department offers a powerful case study for any industry on leveraging local networks for strategic philanthropy.

ALK appoints veteran Edward Jordan, elevating its North American operations to drive a strategic market offensive in the competitive allergy space.

As AI transforms drug discovery, access to GPU power is critical. A new hybrid model from Hydaway Digital could unlock speed and efficiency for pharma R&D.

Medical Facilities Corp. renews its share buyback, a bold move signaling undervaluation. But does this strategy signal growth or just financial engineering?

A leadership shake-up at a top logistics firm reveals a push for digital transformation. What does this mean for the future of the pharma supply chain?

A Thanksgiving greeting from a clean tech firm reveals a strategic dividend. We dissect how microcaps use narration to drive momentum in high-risk sectors.

Successful long-term toxicology data for HER-096 builds on Phase 1b success, solidifying its path to a pivotal Phase 2 trial for Parkinson's disease.

A new venture pioneers Tesla's business program, blending high-speed charging with lifestyle hubs. Is Suncoast Charging's model the future of EV networks?